KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 75 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,587,000 | -98.8% | 316,133 | +8307.8% | 1.47% | -63.2% |
Q2 2022 | $383,233,000 | +3446.8% | 3,760 | -99.0% | 4.00% | +64.1% |
Q1 2022 | $10,805,000 | +113.3% | 383,233 | 0.0% | 2.44% | +115.9% |
Q4 2021 | $5,066,000 | -24.2% | 383,233 | 0.0% | 1.13% | -30.0% |
Q3 2021 | $6,687,000 | -1.5% | 383,233 | +35.3% | 1.61% | -10.0% |
Q2 2021 | $6,786,000 | +23.7% | 283,233 | +32.0% | 1.79% | +23.5% |
Q1 2021 | $5,486,000 | +62.8% | 214,533 | +20.9% | 1.45% | +57.7% |
Q4 2020 | $3,369,000 | +50.9% | 177,433 | 0.0% | 0.92% | +27.6% |
Q3 2020 | $2,232,000 | -0.6% | 177,433 | 0.0% | 0.72% | -3.5% |
Q2 2020 | $2,246,000 | +29.8% | 177,433 | -22.0% | 0.75% | -5.3% |
Q1 2020 | $1,731,000 | -64.8% | 227,433 | -18.0% | 0.79% | -55.5% |
Q4 2019 | $4,924,000 | +139.3% | 277,433 | +56.4% | 1.77% | +86.5% |
Q3 2019 | $2,058,000 | -50.6% | 177,433 | -5.4% | 0.95% | -38.4% |
Q2 2019 | $4,165,000 | -31.3% | 187,599 | -12.0% | 1.54% | -31.1% |
Q1 2019 | $6,062,000 | +22.4% | 213,061 | -33.3% | 2.24% | -27.1% |
Q4 2018 | $4,954,000 | -9.4% | 319,444 | -0.9% | 3.07% | +18.3% |
Q3 2018 | $5,467,000 | +109.3% | 322,436 | 0.0% | 2.60% | +159.0% |
Q2 2018 | $2,612,000 | -13.2% | 322,436 | 0.0% | 1.00% | -14.5% |
Q1 2018 | $3,008,000 | -4.1% | 322,436 | 0.0% | 1.17% | +6.1% |
Q4 2017 | $3,137,000 | +46.1% | 322,436 | 0.0% | 1.11% | +32.3% |
Q3 2017 | $2,147,000 | -5.7% | 322,436 | 0.0% | 0.84% | -3.4% |
Q2 2017 | $2,276,000 | -9.6% | 322,436 | 0.0% | 0.86% | -10.3% |
Q1 2017 | $2,518,000 | +15.2% | 322,436 | 0.0% | 0.96% | -2.1% |
Q4 2016 | $2,186,000 | – | 322,436 | – | 0.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |